You are here

Introduction

Recent years have seen much progression in learning about the biology of lung cancer cells and the mechanisms that control their growth and spread. This has led to define biomarkers and oncogenic drivers, to develop new screening systems such as liquid biopsy and improving patients outcome with targeted strategies and immunotherapies.

The Resource Center “Milestones in NSCLC” is dedicated to providing you with groundbreaking discoveries in diagnosis and management of NSCLC. Our aim is to supply health care professionals with clinically relevant information to enhance knowledge about lung cancer and help meet the challenges faced in today’s medical practice.

We will offer you selected articles from peer-reviewed journals, expert commentaries, patient case reports, interviews, and webcasts. This freely available resource center, hosted by the Journal of Thoracic Oncology, will function as a hub of information for healthcare professionalsand all content is subject to an independent editorial review.

New content will be posted monthly, and the Editors encourage you to visit “Milestones in NSCLC” regularly to stay up to date with recent scientific developments in lung cancer. Please subscribe to our e-Alert to ensure you are informed of all new content as it is published on this platform.

If you have any questions or suggestions feel free to leave them in the comment section. Any of your proposals are welcome.

Stay informed

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Society partner

Made possible by an educational grant from

Please note that Lilly Oncology has no editorial control over the content of this Resource Centre. The Resource Centre and all content therein has been subjected to an independent editorial review.

A few pearls from ELCC 2017

5-8 May 2017, Geneva

by Stefan Zimmermann

A high-level forum where critical issues we face as thoracic oncologists are discussed, and cutting-edge new research is presented. 

Perspectives in Lung Cancer 2017

How I optimize treatment for my NSCLC patients with advanced and aggressive disease


Now available: Webcast on demand


 

ECCO 2017

Debating the optimal management in advanced and metastatic lung cancer: The right treatment for the right patient at the right time


Did you miss the Satellite Symposium?

Now available: Webcast on demand


This educational activity is provided by Elsevier. Independent sponsorship for this educational activity was provided by Lilly Oncology.

Interactive Case Reports

Read more about recent cases from the Journal of Thoracic Oncology. Test your knowledge and answer the questions following the case to get immediate feedback.